Sagittarius Life Science Corp (TPEX:3205)

Sagittarius Life Science Revenue

Sagittarius Life Science had revenue of 188.12M TWD in the quarter ending June 30, 2026, with 66.94% growth. This brings the company's revenue in the last twelve months to 467.69M, up 4.86% year-over-year. In the year 2025, Sagittarius Life Science had annual revenue of 346.08M, down -26.01%.

• Revenue (ttm): 467.69M
• Revenue Growth: +4.86%
• P/S Ratio: 6.76
• Revenue / Employee: 4.18M
• Employees: 112
• Market Cap: 3.16B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	346.08M	-121.67M	-26.01%
Dec 31, 2024	467.75M	27.29M	6.20%
Dec 31, 2023	440.46M	-88.61M	-16.75%
Dec 31, 2022	529.07M	-58.55M	-9.96%
Dec 31, 2021	587.61M	29.43M	5.27%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 7, 2026

Data Sources Report a data error